Cargando…
Association of overexpressed carboxyl-terminal amyloid precursor protein in brains with altered glucose metabolism and liver toxicity
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease. The deposition of amyloid plaques mainly composed of amyloid beta (Aβ) is observed in brain regions in AD patients. AD presents with similar pathophysiology to that of metabolic syndrome, including glucose and insulin resistan...
Autores principales: | Hong, Sungguan, Hong, Seungwoo, Lee, Sung Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075522/ https://www.ncbi.nlm.nih.gov/pubmed/37033452 http://dx.doi.org/10.1080/19768354.2023.2197761 |
Ejemplares similares
-
Extracellular vesicles: where the amyloid precursor protein carboxyl‐terminal fragments accumulate and amyloid‐β oligomerizes
por: Pérez‐González, Rocío, et al.
Publicado: (2020) -
Molecular mechanism of the intramembrane cleavage of the β-carboxyl terminal fragment of amyloid precursor protein by γ-secretase
por: Morishima-Kawashima, Maho
Publicado: (2014) -
Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein
por: Kaur, Gurjinder, et al.
Publicado: (2016) -
Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission
por: Kreis, Anna, et al.
Publicado: (2021) -
The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells
por: Kokawa, Asuka, et al.
Publicado: (2015)